The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Home
Audio Interview: FDA Progress Report and QbD Update
Emil Ciurczak speaks with Moheb Nasr, director of FDA's Office of Drug Quality, on developments at the Agency and Quality by Design (QbD).
Feb. 7, 2008
Click below to listen.
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Celltrion to buy US biologics manufacturing plant as part of tariff response strategy
‘Cobots’ drive pharma’s shift toward scalable cell therapies
Sponsored
OnTrak Wireless: Total Bearing Health Solution
Sponsored
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Trending
Lonza confirms full-year 2025 outlook for CDMO business amid geopolitical uncertainty
Thermo Fisher CEO says Most Favored Nation and tariff policies are better than feared
Editor’s (re)View: Lonza and Thermo Fisher roll on despite volatility in business environment
Sponsored Picks
Sponsored
OnTrak Wireless: Total Bearing Health Solution
Sponsored
AI-Powered QMS: The Future of Quality Management
Sponsored
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Load More Content